The Oncology Institute, Inc. TOI Florida — Deferred tax asset, valuation allowance

Other geography segments

Similar metrics at other companies

GETYUNITED STATES — Deferred tax assets, valuation allowance

$194.5M+33.3%

MATVUnited States — Valuation allowance on deferred tax assets

$81.7M+85.7%

DNOWUS And Non US — Deferred Tax Assets Valuation Allowance

$88M+319%

BCUnited States — Deferred Tax Assets, Valuation Allowance

$54M-5.8%

BLMNU.S. — Deferred tax assets, valuation allowance

$1.4M+55.6%

WTRGValuation Allowance For State Deferred Tax Assets

-$3.69M-251%

Questions, answered.

What is The Oncology Institute, Inc.'s florida — deferred tax asset, valuation allowance?

The Oncology Institute, Inc. (TOI) reported florida — deferred tax asset, valuation allowance of $93K in Q4 2025.

How has The Oncology Institute, Inc.'s florida — deferred tax asset, valuation allowance changed year-over-year?

The Oncology Institute, Inc.'s florida — deferred tax asset, valuation allowance decreased by 6.1% year-over-year, from $99K to $93K.

What does florida — deferred tax asset, valuation allowance mean?

This metric represents the valuation allowance established against deferred tax assets specifically attributable to operations within the Florida geographic segment. It reflects management's assessment of the likelihood that the company will generate sufficient future taxable income to realize the tax benefits associated with these assets. An increase in this allowance indicates a higher degree of uncertainty regarding the recoverability of tax assets in this region.